OakChart

Biohaven Ltd

BHVNHealthcare·Biotechnology·USA·Mid·NYSE·Nov 11 • 3:59 PM ET

15.19+0.08 (0.53%)
2026-11-12 05:38 CET
Market cap
2,294.59 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-542.68 USD m
Free cash flow, TTM
-473.17 USD m
EPS diluted, TTM
-3.86
P/E
-
Compare

Price

BHVN against its 20, 50 and 200-day averages
2050200miss
10.0012.5015.0017.5015.3M30.5MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BHVNclose 15.1920-day 14.1450-day 13.59200-day 12.3115.1952w high

16.7% under the 52-week high of 18.24 on 26 Aug 2026. 52-week low 7.48 on 11 Nov 2025. Last 15 sessions, 20.8% high to low

Volume 0.49× normal · the line is the 50-bar volume average

Profile

BHVN
52-week range, 72% of the way up
7.4818.24

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

IndexRUT
Employees274
IPOMay 04, 2017
Beta3.13
ATR, 14d1.04
Rel volume0.49
Short float11.68%
Insider own14.89%
Inst own91.46%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.29B
Enterprise Value2.43B
Income-542.68M
Sales0.00M
Book/sh-0.65
Cash/sh1.07
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees274
IPOMay 04, 2017

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B-
P/C14.17
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio3.05
Current Ratio3.05
Debt/Eq-
LT Debt/Eq-
Option/ShortYes / Yes

Earnings

EPS (ttm)-3.86
EPS next Y-2.33
EPS next Q0.25
EPS this Y66.21%
EPS next Y-0.50%
EPS next 5Y32.90%
EPS past 3/5Y6.37% -30.08%
Sales past 3/5Y- -
EPS Y/Y TTM49.16%
Sales Y/Y TTM-
EPS Q/Q47.78%
Sales Q/Q-
EarningsOct 29 AMC
EPS/Sales Surpr.-9.79% -100.00%

Ownership

Insider Own14.89%
Insider Trans0.00%
Inst Own91.46%
Inst Trans-5.19%
ROA-161.32%
ROE-799.46%
ROIC-274.84%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA207.43%
SMA5011.74%
SMA20023.40%
Trades-

Technical

Shs Outstand151.06M
Shs Float128.57M
Short Float11.68%
Short Ratio4.63
Short Interest15.01M
52W High18.24 -16.72%
52W Low7.48 103.07%
Volatility6.71% 7.23%
ATR (14)1.04
RSI (14)56.70
Beta3.13
Rel Volume0.49
Avg Volume3.24M
Volume1,597,621

Performance

Perf Week-0.33%
Perf Month33.01%
Perf Quarter2.29%
Perf Half Y68.22%
Perf YTD34.54%
Perf Year78.29%
Perf 3Y-46.89%
Perf 5Y-
Perf 10Y-
Recom1.80
Target Price25.00
Prev Close15.11
Price15.19
Change %0.53%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 08, 2026DowngradeRRBC Capital MktsOutperform → Sector Perform$19+25.1%
Jun 29, 2026DowngradeBBofA SecuritiesNeutral → Underperform$11-27.6%
Apr 13, 2026InitiatedCCanaccord GenuityBuy$21+38.2%
Feb 06, 2026InitiatedGGoldmanBuy$23+51.4%
Jan 21, 2026UpgradeRRBC Capital MktsSector Perform → Outperform$22+44.8%
Dec 03, 2025DowngradeHH.C. WainwrightBuy → Neutral$11-27.6%
Nov 26, 2025DowngradeUUBSBuy → Neutral$11-27.6%
Nov 06, 2025DowngradeBBernsteinOutperform → Mkt Perform$9-40.8%
Nov 05, 2025DowngradeBBofA SecuritiesBuy → Neutral$10-34.2%
Sep 17, 2025InitiatedCCitigroupBuy$28+84.3%

Peers

Mkt cap
TickerCompanyMkt cap
XENEXenon Pharmaceuticals Inc4.14B
PRAXPraxis Precision Medicines Inc9.68B
RAPPRapport Therapeutics Inc1.60B
PTCTPTC Therapeutics Inc5.42B
IMVTImmunovant Inc7.67B
SRRKScholar Rock Holding Corp5.68B
DRUGBright Minds Biosciences Inc231.32M
ARGXArgen X SE ADR61.48B
BIIBBiogen Inc37.46B
NBIXNeurocrine Biosciences Inc17.65B

Insider trading

9 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Gentile KimberlySVP, Clinical OperationsJan 05 '26Option Exercise0.003,7500101,513Jan 07 09:34 PM
Buten MatthewChief Financial OfficerJan 05 '26Option Exercise0.004,2500198,246Jan 07 09:33 PM
Coric VladChief Executive OfficerJan 05 '26Option Exercise0.0014,25001,811,398Jan 07 09:32 PM
Car BruceChief Scientific OfficerJan 05 '26Option Exercise0.004,750010,096Jan 07 09:32 PM
Clark George C.VP, Chief Accounting OfficerJan 05 '26Option Exercise0.002,500068,095Jan 07 09:31 PM
Clark George C.VP, Chief Accounting OfficerNov 17 '25Buy8.5217,000144,77020,000Nov 18 07:29 AM
Bailey GregoryDirectorNov 13 '25Buy7.50400,0003,000,0002,020,071Nov 17 07:31 AM
CHILDS JOHN WDirectorNov 13 '25Buy7.503,333,33324,999,9985,653,904Nov 17 07:30 AM
Coric VladChief Executive OfficerNov 13 '25Buy7.50666,6664,999,9951,195,275Nov 17 07:30 AM

Held by

AUM
TickerCompanyAUM
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
IWMiShares Russell 2000 Index FundAUM: 77.38B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IBBiShares Biotechnology ETFAUM: 11.36B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
PINKSimplify Health Care ETFAUM: 350.61M
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
VHTVanguard Health Care ETFAUM: 21.51B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-29-0.860-0.783-0.8600.0063.6412
2026Q22026-08-10-0.910-0.761-0.9120.000.0014
2026Q12026-05-04-0.880-0.831-0.8840.000.2712
2025Q42026-03-02-1.210-1.188-1.2110.000.0014
2025Q32025-11-10-1.640-1.901-1.6390.000.3815
2025Q22025-08-11-1.940-1.902-1.9360.000.0013
2025Q12025-05-12-2.170-1.700-2.1750.000.0015
2024Q42025-03-03-1.850-1.575-1.8490.000.0015
2024Q32024-11-12-1.700-1.702-1.6990.000.0014
2024Q22024-08-08-3.640-1.781-3.6430.000.0012
2024Q12024-05-09-2.200-1.549-2.2000.000.0011
2023Q42024-02-29-1.810-1.411-1.8110.000.0011
2023Q32023-11-14-1.500-1.326-1.5010.000.005
2023Q22023-07-31-1.320-1.182-1.3240.000.007
2023Q12023-05-12-1.030-1.409-1.0340.000.006
2022Q42023-03-23-3.320-1.219-2.9490.000.006

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2022FY-12.750-9.788-8.3630.000.00
2023FY-5.730-5.221-5.7330.000.00
2024FY-9.280-8.891-9.2770.000.00
2025FY-6.860-6.609-6.8600.000.00
2026FY--2.318--166.67
2027FY--2.329--107.66
2028FY--2.072--163.59
2029FY--0.778--396.64
2030FY-1.026--801.01

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-301130156.360.00430
2026Q4S2026-10-2910201130.00430
2026Q4S2026-10-2310201130.00430
2026Q4S2026-10-0791077.780.00350
2026Q4S2026-08-2890038.890.00350
2026Q4S2026-08-26100035.000.00350
2026Q4S2026-08-139000.000.000.00
2026Q4S2026-08-1111000.000.000.00
2026Q4S2026-07-2111000.000.000.00
2026Q4S2026-06-2112000.000.000.00
2026Q4S2026-05-2013000.000.000.00
2026Q4S2026-05-1813000.900.0011.76
2026Q4S2026-05-0512000.980.0011.76
2026Q4S2026-04-1011001.070.0011.76

Estimate history

EPS, annual-1.843-3.321-8.363-5.733-9.277-6.865-3.8628
Period202020212022202320242025TTM
EPS, quarterly-1.699-1.849-2.175-1.936-1.639-1.211-0.884-0.912-0.856
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual0000000
Period202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual64.37664.37668.1981.116101.222132.775151.055
Period202020212022202320242025MRQ
Shares, quarterly94.899101.222102.104105.782105.804132.775150.506151.018151.055
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Total Revenue0.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A2.864.143.923.371.391.390.07
Gross Profit-2.86-4.14-3.92-3.37-1.39-1.39-0.07
Selling, General and Administrative Excl. Other521.62741.24881.19432.68566.55217.51114.43
Research and Development428.44635.07795.87373.28437.07181.4998.46
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-524.48-745.38-885.11-436.05-567.93-218.90-114.51
Interest Expense--0.000.00-0.000.00
Unusual Expense20.62-0.730.000.000.000.000.00
Net Income Before Taxes-541.73-737.38-845.69-409.55-569.84-212.43-118.67
Income Taxes0.951.440.73-1.380.441.370.00
Consolidated Net Income-542.68-738.82-846.42-408.17-570.28-213.80-118.67
Net Income From Continuing Operations-542.68-738.82-846.42-408.17-570.28-213.80-118.67
Net Income-542.68-738.82-846.42-408.17-570.28-213.80-118.67
EPS (Recurring)-3.50-6.87-9.28-5.73-8.36-3.32-1.84
EPS (Basic, Before Extraordinaries)-3.86-6.86-9.28-5.73-8.36-3.32-1.84
EPS (Diluted)-3.86-6.86-9.28-5.73-8.36-3.32-1.84
EBITDA-521.62-741.24-881.19-432.68-566.55-217.51-114.43
Non-Operating Income (Expense)3.387.2739.4226.50-1.916.47-4.16
Other After Tax Adjustments0.000.000.000.000.000.000.00
Stock Option Compensation Expense65.5988.7756.8522.74152.9147.9229.50
Shares Outstanding151.06132.78101.2281.1268.1964.3864.38
Market Capitalization2,294.592,294.593,776.912,925.98946.07946.07-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.570.620.710.961.101.061.011.00
Gross Profit-0.57-0.62-0.71-0.96-1.10-1.06-1.01-1.00
Selling, General and Administrative Excl. Other125.85124.28129.72141.77168.28210.64220.55188.93
Research and Development101.85100.81103.83121.94141.17184.37187.58167.47
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-126.42-124.90-130.43-142.73-169.38-211.70-221.56-189.93
Interest Expense------0.000.00
Unusual Expense4.8114.643.01-1.84-2.770.000.000.00
Net Income Before Taxes-129.34-136.92-130.26-145.20-173.22-197.89-221.07-186.79
Income Taxes-0.060.390.270.350.220.260.610.05
Consolidated Net Income-129.28-137.31-130.53-145.56-173.44-198.15-221.68-186.84
Net Income From Continuing Operations-129.28-137.31-130.53-145.56-173.44-198.15-221.68-186.84
Net Income-129.28-137.31-130.53-145.56-173.44-198.15-221.68-186.84
EPS (Recurring)-0.83-0.84-0.87-1.22-1.66-1.94-2.17-1.85
EPS (Basic, Before Extraordinaries)-0.86-0.91-0.88-1.21-1.64-1.94-2.17-1.85
EPS (Diluted)-0.86-0.91-0.88-1.21-1.64-1.94-2.17-1.85
EBITDA-125.85-124.28-129.72-141.77-168.28-210.64-220.55-188.93
Non-Operating Income (Expense)1.892.623.18-4.31-6.6113.810.493.14
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense14.7115.1422.3513.3917.0116.4441.9210.03
Shares Outstanding151.06151.02150.51132.78105.80105.78102.10101.22
Market Capitalization2,294.592,240.351,272.531,498.051,587.921,440.812,453.643,776.91

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY
Cash & Short Term Investments319.91486.27383.14500.6776.3182.51
Short Term Receivables0.002.6013.6546.149.910.00
Inventories0.000.000.000.000.000.00
Other Current Assets48.4149.6145.6640.168.617.25
Total Current Assets368.33538.47442.45586.9794.8289.76
Net Property, Plant & Equipment61.0253.7148.5852.4418.2313.56
Total Investments and Advances2.293.132.402.406.758.18
Intangible Assets19.7919.7919.7919.7919.790.00
Other Assets0.010.000.000.192.470.01
Total Assets451.45615.11513.21661.78142.06111.50
Short Term Debt Incl. Current Port. of LT Debt5.763.803.3138.230.440.68
Accounts Payable11.6418.0315.5810.700.000.00
Other Current Liabilities98.53132.4036.5441.0941.5029.20
Total Current Liabilities115.93154.2355.4290.0241.9429.88
Long Term Debt278.8632.7827.5730.582.802.93
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities4.584.662.252.412.641.91
Total Liabilities399.38191.6785.24123.0147.3734.72
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity52.07423.44427.98538.7734.6916.78
Total Shareholders Equity52.07423.44427.98538.7734.6916.78
Accumulated Minority Interest0.000.000.000.0060.0060.00
Total Equity52.07423.44427.98538.7794.6976.78
Total Liabilities & Stockholders Equity451.45615.11513.21661.78142.06111.50
Book Value Per Share0.394.185.287.900.540.26
Tangible Book Value Per Share0.243.995.037.610.230.26
Full-Time Employees274256239202--
Price to Book Ratio-23.3511.2210.099.449.44-
Return on Assets-138.54-150.03-69.48-141.89-168.64-
Return on Equity-310.75-198.83-84.44-198.89-830.73-
Return on Invested Capital-223.26-185.53-89.60-100.16-570.31-602.07
Quick Ratio3.183.497.986.522.263.00
Current Ratio3.183.497.986.522.263.00

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Net Income-542.68-738.82-846.42-408.17-570.28-213.80-118.67
Depreciation9.429.927.866.911.391.390.07
Other Funds (Non Cash)109.77118.11239.3044.92299.8164.9033.66
Funds from Operations-423.49-610.79-599.26-356.34-269.08-147.50-84.93
Extraordinary Item0.000.000.000.000.000.000.00
Changes in Working Capital-49.051.3616.8124.61-28.601.668.98
Cash from Operating Activities-472.53-609.44-582.45-331.73-297.69-145.84-75.96
Capital Expenditures-0.64-0.71-4.05-3.05-41.07-0.94-2.70
Net Assets From Acquisitions0.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.390.000.001.8860.00
Purchase or Sale of Investments11.61303.12-241.32132.88-259.720.000.00
Purchase of Investments-203.39-266.88-745.68-194.12-259.720.000.00
Sale Or Maturity of Investments215.00570.00504.36327.000.000.000.00
Other Uses0.00-1.850.000.00-4.000.000.00
Other Sources0.000.000.000.000.000.000.00
Cash from Investing Activities10.96300.56-244.97129.83-304.790.9457.30
Cash Dividends Paid0.000.000.000.000.000.000.00
Change in Capital Stock372.01189.31675.52247.12282.80138.0592.24
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00
Sale of Common Pref Stock372.01189.31675.52247.12282.80138.0592.24
Proceedsfrom Stock Options370.18187.48675.52247.12282.80138.0592.24
Issuance or Reduction of Debt, Net0.00250.000.000.00449.130.000.00
Change in Long Term Debt0.00250.000.000.000.000.000.00
Issuance of Long Term Debt0.00250.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.19-0.192.26-35.2135.660.400.00
Other Financing Activities Uses-0.19-0.190.00-35.210.000.000.00
Cash from Financing Activities371.82439.12677.77211.91767.60138.4592.24
Exchange Rate Effect0.02-0.000.07-0.500.43--
Net Change in Cash-89.73130.24-149.589.52165.55-6.4573.59
Free Cash Flow-473.17-610.15-586.50-334.77-303.76-146.78-78.65
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments161.90267.97349.55319.91260.77405.23
Short Term Receivables0.000.000.000.000.000.00
Inventories0.000.000.000.000.000.00
Other Current Assets29.6228.5936.1048.4162.8469.60
Total Current Assets191.51296.56385.65368.33323.62474.83
Net Property, Plant & Equipment50.2351.8958.6661.0262.7252.84
Total Investments and Advances2.132.492.302.292.982.95
Intangible Assets19.7919.7919.7919.7919.7919.79
Other Assets0.010.010.010.010.010.01
Total Assets263.68370.74466.41451.45409.12550.41
Short Term Debt Incl. Current Port. of LT Debt4.744.675.905.765.514.70
Accounts Payable13.5312.1110.4211.6417.4919.63
Other Current Liabilities44.4945.8835.7598.5390.02100.00
Total Current Liabilities62.7762.6652.08115.93113.02124.32
Long Term Debt295.70292.37280.27278.86308.66286.87
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities3.463.494.564.584.604.64
Total Liabilities361.92358.52336.91399.38426.28415.83
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-98.2512.22129.5052.07-17.16134.59
Total Shareholders Equity-98.2512.22129.5052.07-17.16134.59
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity-98.2512.22129.5052.07-17.16134.59
Total Liabilities & Stockholders Equity263.68370.74466.41451.45409.12550.41
Book Value Per Share-0.650.080.860.39-0.161.27
Tangible Book Value Per Share-0.78-0.050.730.24-0.351.09
Full-Time Employees---274--
Price to Book Ratio-23.3517.2921.57-69.6111.805.55
Return on Assets-161.32-127.41-139.99-138.54-169.65-135.38
Return on Equity--799.46-333.00-310.75-522.08-295.94
Return on Invested Capital-65.47-45.08-31.85-43.98-59.50-47.02
Quick Ratio3.054.737.413.182.863.82
Current Ratio3.054.737.413.182.863.82

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-129.28-137.31-130.53-145.56-173.44-198.15
Depreciation2.222.262.372.573.121.98
Other Funds (Non Cash)23.0233.2831.3222.1427.619.68
Funds from Operations-104.03-101.77-96.85-120.84-142.71-186.49
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-2.8216.67-53.07-9.82-3.0118.56
Cash from Operating Activities-106.85-85.10-149.92-130.66-145.72-167.94
Capital Expenditures-0.18-0.450.00-0.01-0.01-0.23
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-35.1545.2815.21-13.73165.00-13.48
Purchase of Investments-65.15-29.72-19.79-88.730.00-133.48
Sale Or Maturity of Investments30.0075.0035.0075.00165.00120.00
Other Uses0.000.000.000.00-0.02-1.83
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-35.3344.8215.21-13.74164.97-15.55
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.213.80179.02188.990.12-0.17
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.213.80179.02188.990.12-0.17
Proceedsfrom Stock Options4.140.00178.88187.160.12-0.17
Issuance or Reduction of Debt, Net0.000.000.000.000.00250.00
Change in Long Term Debt0.000.000.000.000.00250.00
Issuance of Long Term Debt0.000.000.000.000.00250.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.00-0.190.000.00
Other Financing Activities Uses0.000.000.00-0.190.000.00
Cash from Financing Activities0.213.80179.02188.800.12249.83
Exchange Rate Effect0.000.000.020.000.01-0.04
Net Change in Cash-141.97-36.4844.3344.4019.3966.31
Free Cash Flow-107.03-85.55-149.92-130.67-145.73-168.17

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.68%15.0M128.6M3.14M
2026-10-1513.92%17.9M128.6M2.61M
2026-09-3014.82%19.1M128.6M2.72M
2026-09-1515.91%20.4M128.6M3.02M
2026-08-3114.79%19.0M128.5M3.02M
2026-08-1413.87%17.8M128.5M2.83M
2026-07-3114.52%18.2M125.2M2.88M
2026-07-1515.42%19.3M125.5M2.85M
2026-06-3016.32%20.5M125.5M2.80M
2026-06-1520.34%25.5M125.4M2.38M
2026-05-2920.13%25.2M125.4M2.29M
2026-05-1519.21%24.1M125.4M2.12M
2026-04-3019.83%24.9M125.4M2.20M
2026-04-1518.98%23.8M125.3M2.33M
2026-03-3118.65%23.8M127.5M2.64M
2026-03-1317.18%21.9M127.5M2.79M
2026-02-2716.50%21.0M127.5M2.83M
2026-02-1317.48%21.5M123.0M3.20M
2026-01-3016.40%20.7M126.3M4.24M
2026-01-1516.41%20.7M126.3M4.12M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call4.0010.2012.700.0011.5750.000.000.989-0.0180.001
call5.009.2011.800.009.9750.000.000.987-0.0170.001
call6.008.2010.700.008.2270.000.000.984-0.0170.001
call7.007.209.700.007.0940.000.000.981-0.0170.001
call8.006.208.700.006.1510.000.000.978-0.0170.001
call9.005.507.005.653.9934.000.000.920-0.0580.004
call10.004.605.705.702.8204.000.000.905-0.0560.004
call11.003.604.805.252.53315.000.000.886-0.0520.005
call12.002.803.703.001.9106530.000.861-0.0480.005
call13.002.102.652.401.4151447.000.770-0.0690.007
call14.001.051.851.401.2551931000.683-0.0720.008
call15.000.401.251.151.2123910.000.569-0.0640.009
call16.000.250.500.580.8591690.000.426-0.0610.009
call17.000.050.450.261.1242140.000.294-0.0520.008
call18.000.000.250.221.1082390.000.188-0.0400.006
call19.000.001.000.221.32225.000.000.165-0.0440.006
call20.000.000.250.051.5154432.000.149-0.0470.005
call21.000.002.150.001.6910.000.000.138-0.0500.005
call22.000.002.150.001.8520.000.000.129-0.0520.005
call23.000.002.150.002.0030.000.000.121-0.0540.005
call24.000.000.950.002.1430.000.000.116-0.0560.005
call25.000.000.950.002.2750.000.000.111-0.0580.004
call26.000.000.950.002.4000.000.000.106-0.0590.004
call27.000.000.950.002.5180.000.000.103-0.0600.004
call28.000.000.950.002.6300.000.000.100-0.0620.004
call29.000.000.950.002.7360.000.000.097-0.0630.004
call30.000.000.950.002.8380.000.000.094-0.0640.004
put4.000.000.950.004.4130.000.00-0.011-0.0170.001
put5.000.000.950.003.7110.000.00-0.013-0.0170.001
put6.000.000.950.003.1430.000.00-0.016-0.0170.001
put7.000.000.950.002.6670.000.00-0.019-0.0160.001
put8.000.000.050.002.1240.000.00-0.023-0.0140.001
put9.000.002.150.002.8640.000.00-0.080-0.0570.004
put10.000.002.150.102.40923.000.00-0.095-0.0540.004
put11.000.002.150.101.98919.000.00-0.114-0.0510.005
put12.000.050.300.301.5953990.00-0.139-0.0470.005
put13.000.000.600.401.66330.000.00-0.230-0.0670.007
put14.000.100.850.391.5234450.00-0.317-0.0710.008
put15.000.451.000.701.1852,2820.00-0.431-0.0620.009
put16.000.002.401.282.06426.000.00-0.574-0.0590.009
put17.001.702.752.031.72922.000.00-0.706-0.0500.008
put18.002.403.600.001.8560.000.00-0.812-0.0380.006
put19.003.204.700.002.2330.000.00-0.835-0.0420.006
put20.004.105.700.002.4680.000.00-0.851-0.0450.005
put21.005.006.600.002.5560.000.00-0.862-0.0480.005
put22.005.907.800.003.0010.000.00-0.871-0.0500.005
put23.006.908.600.002.9280.000.00-0.879-0.0520.005
put24.007.909.800.003.3570.000.00-0.884-0.0530.005
put25.008.9010.600.003.2500.000.00-0.889-0.0550.004
put26.009.7011.800.003.6670.000.00-0.894-0.0560.004
put27.0010.7013.100.004.1920.000.00-0.897-0.0580.004
put28.0011.7014.100.004.3300.000.00-0.900-0.0590.004
put29.0012.7015.100.004.4610.000.00-0.903-0.0600.004
put30.0013.7016.100.004.5860.000.00-0.906-0.0610.004

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-298-KCurrent report2026-10-29SEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-228-KCurrent report2026-10-22SEC
2026-10-158-KCurrent report2026-10-08SEC
2026-09-174Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-108-KCurrent report2026-09-04SEC
2026-08-268-KCurrent report2026-08-26SEC
2026-08-143Initial statement of beneficial ownership of securities2026-08-06SEC
2026-08-14SCHEDULE 13GSEC
2026-08-108-KCurrent report2026-08-10SEC
2026-08-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-078-KCurrent report2026-08-03SEC
2026-07-173Initial statement of beneficial ownership of securities2026-07-09SEC
2026-07-098-KCurrent report2026-07-09SEC
2026-07-08SCHEDULE 13G/ASEC
2026-05-278-KCurrent report2026-05-26SEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-058-KCurrent report2026-05-04SEC
2026-05-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-048-KCurrent report2026-05-04SEC
2026-05-048-KCurrent report2026-04-28SEC
2026-05-04424B5SEC
2026-05-04S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersSEC
2026-04-304Statement of changes in beneficial ownership of securities2026-04-28SEC
2026-04-304Statement of changes in beneficial ownership of securities2026-04-28SEC
2026-04-304Statement of changes in beneficial ownership of securities2026-04-28SEC
2026-04-304Statement of changes in beneficial ownership of securities2026-04-28SEC
2026-04-304Statement of changes in beneficial ownership of securities2026-04-28SEC
2026-04-304Statement of changes in beneficial ownership of securities2026-04-28SEC
2026-04-304Statement of changes in beneficial ownership of securities2026-04-28SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-1133.14M400

Institutional holders

Manager% owned
BlackRock, Inc.8.77%
MONTANOVA CAPITAL, LLC6.83%
STIFEL FINANCIAL CORP6.60%
Jupiter Topco LLC5.70%
Woodline Partners LP5.09%
STATE STREET CORP4.61%
INFINITUM ASSET MANAGEMENT, LLC4.15%
D. E. Shaw & Co., Inc.2.78%
AQR CAPITAL MANAGEMENT LLC2.76%
Royalty Pharma Sub-Manager, LLC1.95%

Funds

Fund% owned
State Street(R) SPDR(R) S&P(R) Biotech ETF2.52%
iShares Russell 2000 ETF2.31%
Select Biotechnology Portfolio1.44%
VANGUARD EXTENDED MARKET INDEX FUND0.99%
Fidelity Small Cap Index Fund0.97%
Janus Henderson Global Life Sciences Fund0.89%
iShares Russell 2000 Growth ETF0.82%
SMALLCAP World Fund Inc0.78%
Janus Henderson Triton Fund0.77%
Simplify Health Care ETF0.69%

OakChart. BHVN. Cached 15 minutes.